BUILDING ON TRUST AND COLLABORATION TO ROADMAP NEXT PHASE OF AUSTRALIA’S VACCINE SUCCESS Conference returns to lead charge in strengthening the entire life cycle of vaccine development
With
Leah Goodman
Chief Executive Officer
Biointelect
SEGMENT
Filmed in Sydney | September 2026
Trust, collaboration and a stronger vaccine ecosystem were the focus of the second Australian Vaccine Value Chain Conference, held in Sydney, September 2026 and hosted by life science consultancy Biointelect. More than 200 leaders from government, industry, academia, research, investment and the immunisation community attended, joined by international representatives including the International Vaccine Institute and the Coalition for Epidemic Preparedness Innovations.
The conference took place amid falling global immunisation rates, rising misinformation, shrinking funding and a resurgence of measles. In Australia, childhood immunisation rates have fallen by between 2.3 and 4.3 percentage points at standard age milestones each year since 2020. Discussions covered research funding, regional health security, sovereign manufacturing, data and capacity building, vaccine access, uptake resistance and pandemic preparedness. Delegates noted progress through the new Australian Centre for Disease Control and the updated National Immunisation Strategy, but experts say further action is needed.
In an interview with the Australian Health Journal, Biointelect CEO Leah Goodman said the mood had shifted since the inaugural 2024 conference, when nervousness was evident. This year, she said, attendees were “feeling that they had a role to play in the shaping of the Australian ecosystem.” She pointed to the first six companies announced in the Biointelect Venturer incubator, funded through the Medical Research Future Fund, as a sign of progress.
Goodman also stressed the importance of international cooperation, stating that “no country can build a resilient vaccine ecosystem alone.” A white paper will capture the discussions and set priorities for the next two years.
Source: Adapted from Biointelect media release (September 2026) and transcript
-
Specialist physiotherapist successfully mixes online & in-person
Dr. Kieran Richardson (FACP) is a Specialist Physiotherapist, conferred by the Australian College of Physiotherapists (Australian Physiotherapy Association) in 2016. Dr Richardson is the Director of Global Specialist Physiotherapy, a consultancy company providing online Formal Mentoring and Professional Development individual clinicians, clinics, and groups, as well as Second Opinions to clinicians and directly to patients all around the world.
-
Confronting picture of growing women’s health crisis in uterine cancers
Uterine cancers have become Australia’s fastest-growing women’s cancer, with incidence doubling over the past 25 years and projected to continue to surge. Without immediate action, more than 44,000 women are expected to be diagnosed by 2035, and 8,900 will lose their lives to the disease.
Released November 2025, Australia’s first State of the Nation: Uterine Cancers in Australia 2025 report by the Australia New Zealand Gynaecological Oncology Group (ANZGOG), reveals a confronting picture of a growing women’s health crisis that has gone largely unseen and one that now requires immediate, coordinated national action.
-
Alfred Hospital leading in pharmacy services for critically unwell patients
Cristina Roman, is the Lead Pharmacist at Alfred Emergency Trauma Centre. In her 12 years working in the Emergency Department, Cristina has established pharmacy services, and filled gaps in patient care with new models of care.
One of those models of care adopted by the US and other countries, is involving pharmacists for critically unwell patients that present to the emergency department.
Australian Health Journal spoke with Cristina Roman and Lisa Bremner, Advanced Training Resident Pharmacist at Alfred Hospital Emergency Trauma Centre.
